- 2017March 17
CFDA Proposes to Reform the Process of Imported Drug Approval
Transferred from CFDA
- 2017May 11
CFDA Issues Regulatory Reformation Proposal Draft on Drug Life Cycle Management:Getting Close to Western Regulations
CFDA proposes a regulation reformation draft on life cycle management: shorten the timeline for IND approval, loosen control over clinical trial sites and improve IP protection for…
- 2017July 19
The ICH Assembly approved the China Food and Drug Administration as a new Regulatory Member
The International Council for Harmonization (ICH) met in Montreal, Canada from May 31 to June 1, 2017. The ICH Assembly approved the CFDA as a new Regulatory Member.
- 2017July 13
China's Ministry of Human Resources adds 36 drugs to NDRL after Price Cuts
China will add 36 new drugs to the health insurance list: category B, after price negotiation with the manufacturers.
- 2017October 08
General Office of China Council, General Office of the State Council Issue Proposal on “Further Improve the Drug Registration Process, Advocate Innovation in Drug Development.”
China propel the reformation in drug registration and development from top government level: proposal issued by General Office of China Council ...